Dextromethorphan for Diabetic Macular Edema

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2015

Conditions
Diabetic Macular Edema
Interventions
DRUG

Dextromethorphan hydrobromide

Participants instructed to take 60 mg dextromethorphan capsules orally two times a day for 24 months.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
collaborator

The Emmes Company, LLC

INDUSTRY

lead

National Eye Institute (NEI)

NIH

NCT01441102 - Dextromethorphan for Diabetic Macular Edema | Biotech Hunter | Biotech Hunter